GB0912238D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0912238D0
GB0912238D0 GB0912238A GB0912238A GB0912238D0 GB 0912238 D0 GB0912238 D0 GB 0912238D0 GB 0912238 A GB0912238 A GB 0912238A GB 0912238 A GB0912238 A GB 0912238A GB 0912238 D0 GB0912238 D0 GB 0912238D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0912238A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB0912238A priority Critical patent/GB0912238D0/en
Publication of GB0912238D0 publication Critical patent/GB0912238D0/en
Priority to JP2012500308A priority patent/JP5732036B2/en
Priority to CA2754605A priority patent/CA2754605C/en
Priority to KR1020117024068A priority patent/KR101700229B1/en
Priority to EP10711443.1A priority patent/EP2408772B1/en
Priority to PCT/GB2010/000498 priority patent/WO2010106333A1/en
Priority to MX2011009807A priority patent/MX2011009807A/en
Priority to AU2010224693A priority patent/AU2010224693B2/en
Priority to CN201080021866.0A priority patent/CN102428084B/en
Priority to PE2011001662A priority patent/PE20120506A1/en
Priority to US12/727,754 priority patent/US20100317646A1/en
Priority to RU2011142182/04A priority patent/RU2011142182A/en
Priority to CL2011002267A priority patent/CL2011002267A1/en
Priority to IL215147A priority patent/IL215147A0/en
Priority to US15/478,141 priority patent/US20170320870A1/en
Ceased legal-status Critical Current

Links

GB0912238A 2009-03-19 2009-07-14 Compounds Ceased GB0912238D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB0912238A GB0912238D0 (en) 2009-07-14 2009-07-14 Compounds
RU2011142182/04A RU2011142182A (en) 2009-03-19 2010-03-19 COMPOUNDS
MX2011009807A MX2011009807A (en) 2009-03-19 2010-03-19 Compounds.
CN201080021866.0A CN102428084B (en) 2009-03-19 2010-03-19 Compound
KR1020117024068A KR101700229B1 (en) 2009-03-19 2010-03-19 Compounds
EP10711443.1A EP2408772B1 (en) 2009-03-19 2010-03-19 Compounds
PCT/GB2010/000498 WO2010106333A1 (en) 2009-03-19 2010-03-19 Compounds
JP2012500308A JP5732036B2 (en) 2009-03-19 2010-03-19 Compound
AU2010224693A AU2010224693B2 (en) 2009-03-19 2010-03-19 Compounds
CA2754605A CA2754605C (en) 2009-03-19 2010-03-19 Pyrazolopyridine compounds and their use as lrrk2 inhibitors
PE2011001662A PE20120506A1 (en) 2009-03-19 2010-03-19 PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS
US12/727,754 US20100317646A1 (en) 2009-03-19 2010-03-19 Compounds
CL2011002267A CL2011002267A1 (en) 2009-03-19 2011-09-13 Compound derived from substituted pyrazolopyridine, lrrk2 kinase inhibitor; process of preparing said compound; pharmaceutical composition; pharmaceutical combination; use of the compound to prevent or treat a disorder selected from cancer and neurodegenerative diseases.
IL215147A IL215147A0 (en) 2009-03-19 2011-09-14 Compounds
US15/478,141 US20170320870A1 (en) 2009-03-19 2017-04-03 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0912238A GB0912238D0 (en) 2009-07-14 2009-07-14 Compounds

Publications (1)

Publication Number Publication Date
GB0912238D0 true GB0912238D0 (en) 2009-08-26

Family

ID=41057950

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0912238A Ceased GB0912238D0 (en) 2009-03-19 2009-07-14 Compounds

Country Status (1)

Country Link
GB (1) GB0912238D0 (en)

Similar Documents

Publication Publication Date Title
GB0907425D0 (en) Compounds
EP2393493A4 (en) Compounds
GB0918249D0 (en) Compounds
EP2491025A4 (en) Azaazulene compounds
GB0907515D0 (en) Compounds
GB0914856D0 (en) Compounds
GB0915892D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
GB0919594D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0911000D0 (en) Compounds
GB0909672D0 (en) Compounds
GB0915686D0 (en) Compounds
GB0910197D0 (en) Compounds
GB0919263D0 (en) Compounds
GB0900456D0 (en) Compounds
GB0918473D0 (en) Compounds
GB0902156D0 (en) Compounds
GB0902259D0 (en) Compounds
GB0915789D0 (en) Compounds
GB0905057D0 (en) Compounds
GB0915685D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)